Building on our previous finding that elevated Pentraxin-3 predicts poor outcomes in non-neutropenic IPA, this study shows that NLR also reflects dysregulated host responses, providing complementary prognostic value by integrating immune and pathogen factors (Sun et al., 2025). The gene discussed is PTX3; the disease is Ito hypomelanosis.